Next Quarterly Earnings
Date confirmed from the company's own financial calendar.
Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
Takeda Pharmaceutical is a leading global, research-driven Japanese pharmaceutical company. It focuses on developing and delivering innovative therapies for patients across oncology, gastroenterology, neuroscience, and rare diseases, aiming to improve global health.
Date confirmed from the company's own financial calendar.
Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
Takeda Pharmaceutical is scheduled to report its next quarterly earnings on 10/29/2026. Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
Takeda Pharmaceutical last reported quarterly earnings on 7/30/2026 (Q2 2026). Earnings per share (EPS) came in at 71.65 JPY.
Across its last 5 earnings reports, Takeda Pharmaceutical stock moved by ±1.1% on average the following day. The largest reaction was -2.2% on 07/30/2026; 4 of 5 reactions were positive.
Takeda Pharmaceutical has beaten analyst EPS estimates in 4 of its last 5 evaluated quarters (beat rate: 80%).
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
Basis: price reactions to the last 5 report dates (close to close).
Basis: 5 quarters with an analyst estimate and reported EPS.
Past price reactions are not a reliable indicator of future performance.